9/21/2022
RedChip Logo

RedChip Companies

Weekly Newsletter
 

Save Foods Announces New Sales with Mexican Lime Packers

Save Foods’ (Nasdaq: SVFD) eco-crop protection solution continues to gain traction with exporters. The Company just announced new commercial sales with Mexican lime packers after completing successful pilot tests of Save Foods’ solution. The Company believes growing interest in its solutions from prospective customers in the region will translate into sustained growth.

For more information, visit www.savefoods.co

 
See More Info
 
 
 

Rail Vision’s Long-Term Pilot Program with Rio Tinto Completed and Extended to Evaluate Additional Use Cases

Rail Vision (Nasdaq: RVSN), a technology company seeking to revolutionize railway safety and the data-related market, today announced the completion of a pilot with Rio Tinto Iron Ore for the AutoHaul® project, the world’s first automated, long distance, heavy haul rail network, and the launch of the next phase of testing. Under the AutoHaul® program, Rio Tinto is seeking to add a forward-looking capability to its autonomous trains to detect obstacles on and along the tracks. During the next testing phase of the Rail Vision Main Line System pilot program, Rio Tinto and Hitachi will test different types of obstacles the system can detect at various ranges.


 
Learn More
   

American Resources Corporation to Build 200,000 Square Foot Combined Commercial Scale Lithium Ion Battery and Rare Earth Magnets Recycling Facility

American Resources Corp.’s (Nasdaq: AREC) majority owned subsidiary, ReElement Technologies LLC, has commenced engineering, planning and development for its second lithium-ion battery and rare earth magnet recycling and metal recovery facility utilizing its patented chromatography technology to produce 99.9%+ pure critical battery material and 99.5%+ rare earth elements.

 
Learn More
 

Odyssey Health Achieves Positive Safety Outcomes for Concussion Drug in Multiple Ascending Dosing Trial, Cohort II

Odyssey Health (OTC: ODYY) announced the successful completion of safety measures for the second cohort of their Phase I Multi-Day Ascending Dosing (MAD) clinical trial. Odyssey’s trial involves administering PRV-002, the Company’s novel drug to treat concussion, to healthy human subjects to determine drug safety. For all cohorts of the trial, the drug was found to be safe and well tolerated.

 
Learn More
 

Hempacco Commences Sales of Cheech & Chong-branded CBD Cigarettes

Hempacco (Nasdaq: HPCO) commenced sales of Cheech & Chong-branded hemp smokable products during the third quarter of 2022 under its previously announced 50/50 joint venture. In January 2022, Hempacco entered into a joint venture agreement with Cheech and Chong's Cannabis Company. Hempacco debuted its initial line of Cheech & Chong-branded hemp smokables and hemp blunt wraps products, as well as a Cheech & Chong-branded kiosk vending machine, with Tommy Chong, at the Tobacco Plus Expo in Las Vegas in January.

 
Learn More
 

 
 

Upcoming Events

21
September
2022
NYSE American: CANF - Can-Fite BioPharma Ltd.
11:00am Eastern
Can-Fite BioPharma Ltd. (NYSE American: CANF) is an advanced clinical stage drug development company with a platform technology that addresses multi-billion-dollar markets in the treatment of autoimmune inflammatory diseases including Psoriasis, and liver diseases including advanced liver cancer and NASH.
 
Sign Up
 
21
September
2022
NASDAQ: GLSI - Greenwich LifeSciences
4:15pm Eastern
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and is planning to commence a Phase III clinical trial.
 
Sign Up
 
22
September
2022
NASDAQ: RNAZ - TransCode Therapeutic
4:15pm Eastern
TransCode Therapeutics is developing therapeutic and diagnostic candidates designed to deliver on the promise of RNA in oncology.
 
Sign Up
 
27
September
2022
NASDAQ: SYTA - Siyata Mobile
11:00am Eastern
Siyata Mobile (Siyata or the Company) is a leading developer and distributor of technologically advanced rugged smartphones, in-vehicle mounted IoT cellular communications devices, and cellular signal boosters for global first responders and enterprise customers based on Push-to-Talk Over Cellular (PoC) technology.
 
Sign Up
 
27
September
2022
NASDAQ: OKYO - OKYO Pharma Limited
4:15pm Eastern
OKYO Pharma (OKYO) is a bio-pharmaceutical company focused on the discovery & development of first-in-class pharmaceutical therapies to treat inflammatory eye diseases including dry eye and ocular pain.
 
Sign Up
 
28
September
2022
OTCQB: QYOUF - QYOU Media Inc.
4:15pm Eastern
QYOU Media operates in India and the United States producing and distributing content created by social media stars and digital content creators.
 
Sign Up
 
 
 

Archive Events

14
September
2022
NASDAQ: LTRN - Lantern Pharma
Meeting Duration 44 minutes
Lantern Pharma is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies.
 
Watch Replay
 
13
September
2022
NASDAQ: DPRO - Draganfly
Meeting Duration 38 minutes
Draganfly has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more.
 
Watch Replay
 
13
September
2022
NASDAQ: BRAG - Bragg Gaming Group
Meeting Duration 40 minutes
Bragg Gaming Group is a next generation gaming group with cutting-edge technology, leading brands and world-class management expertise, developing into a global gaming force.
 
Watch Replay
 
8
September
2022
NASDAQ: GENE - Genetic Technologies Limited
Meeting Duration 31 minutes
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health.
 
Watch Replay
 
7
September
2022
OTC: ODYY - Odyssey Health Inc.
Meeting Duration 30 minutes
Odyssey Health Inc. (formerly Odyssey Group International, Inc.) is a technology and asset acquisition company with a focus in the area of life saving medical solutions.
 
Watch Replay
 
 
 

Lesson of the Week

Learn what "beta" is and how it applies to your investments.

 
Learn More
 
 
 
All Videos
Full Episodes
 

RedChip TV

This Week on RedChip TV: Two Revolutionary Medical Small-Cap Stocks

BioVie: Advancing Mid- and Late-Stage Drug Candidates for Alzheimer’s and Parkinson’s

Nutriband: Addressing a Multi-Billion-Dollar Market Opportunity

Draganfly: Capturing the $20 Billion Commercial Drone Market

OKYO Pharma: Targeting the $5 Billion Dry Eye Disease Market

 
 

MidSouth Week in Review

Economists predict a 75 basis points Fed hike next week.

 
Learn More
 
You are receiving this email because your email is subscribed to our mailing list.
Click here to unsubscribe your email address from this list.
Copyright © 2022. All rights reserved.
© 2022 RedChip , All rights reserved